On Sunday, April 20th 2025, starting 8:30am GMT, there will be maintenance work that will involve the website being unavailable during parts of the day. We apologize for any inconvenience this may cause and appreciate your understanding.
We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Colony formation by hematopoietic cells
- Colony stimulating factors (CSFs)
- CSF-1 in development and disease
- Regulation by CSF-1 in development
- CSF-1-deficient (Csf1op/Csf1op) mice
- Biosynthesis and expression of CSF-1
- Csf1 promoter-driven CSF-1 transgenes
- CSF-1R-nullizygous mice
- CSF-1R-nullizygous mice - conclusions
- Interleukin-34 - a novel ligand for the CSF-1R
- CSF-1 transgenic and Csf1r-/- mice
- CSF-1 in disease: insights from animal models
- Blocking CSF-1 action as therapy
- Anti-CSF1 antibody treatment blocks CSF-1 action
- CSF-1 and the CSF-1R in leukemia
- CSF-1 and solid tumors
- CSF-1 blockade inhibits tumor development
- A tumor cell/macrophage paracrine loop
- CSF1/CSF1R mouse genetic models and disease
- Early events in CSF-1 signal transduction
- The macrophage CSF-1R signaling proteome
- CSF-1 signaling proteome interaction map
- MAYP/PSTPIP2
- MAYP/PSTPIP2 and the PCH family
- PCH proteins in vesicle and filopod formation
- Pstpip2 mutations cause inflammatory disease
- Gross phenotype of the Lupo mutation
- Macrophage infiltration in Pstpip2Lp/Lp mice
- Pstpip2Lp/Lp disease
- CSF-1 R structure
- The MacCsf1r-/- (M-/-) macrophage cell line
- Phenotypes of CSF-1R Y->F mutant macrophages
- Morphology of CSF-1R Y->F mutant macrophages
- CSF-1R mutant macrophage cell lines
- Current questions in CSF-1/CSF-1R research
- Acknowledgements
Topics Covered
- Colony stimulating factors
- Action of CSF-1 and its isoforms
- The CSF-1 receptor (CSF-1R) and its new ligand, IL-34
- CSF-1 and the CSF-1R in mouse models of inflammatory disease and cancer
- A proteomic approach CSF-1R signaling
- Action of the downstream signaling molecule, PSTPIP2
- PSTPIP2 mutations cause autoinflammatory disease
- A genetic approach to CSF-1R structure/function and signaling
- Current questions
Talk Citation
Stanley, E.R. (2009, May 31). Colony stimulating factor-1 regulation of macrophages in development and disease [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved April 15, 2025, from https://doi.org/10.69645/WULU3350.Export Citation (RIS)
Publication History
- Published on May 31, 2009
Financial Disclosures
- Prof. E. Richard Stanley has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Colony stimulating factor-1 regulation of macrophages in development and disease
Published on May 31, 2009
50 min
A selection of talks on Immunology & Inflammation
Hide